Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score

Even though there is a clear link between Alzheimer's Disease (AD) related neuropathology and cognitive decline, numerous studies have observed that healthy cognition can exist in the presence of extensive AD pathology, a phenomenon sometimes called Cognitive Resilience (CR). To better understa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-11, Vol.15 (11), p.e0241707-e0241707
Hauptverfasser: Yao, Tianyi, Sweeney, Elizabeth, Nagorski, John, Shulman, Joshua M, Allen, Genevera I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0241707
container_issue 11
container_start_page e0241707
container_title PloS one
container_volume 15
creator Yao, Tianyi
Sweeney, Elizabeth
Nagorski, John
Shulman, Joshua M
Allen, Genevera I
description Even though there is a clear link between Alzheimer's Disease (AD) related neuropathology and cognitive decline, numerous studies have observed that healthy cognition can exist in the presence of extensive AD pathology, a phenomenon sometimes called Cognitive Resilience (CR). To better understand and study CR, we develop the Alzheimer's Disease Cognitive Resilience Score (AD-CR Score), which we define as the difference between the observed and expected cognition given the observed level of AD pathology. Unlike other definitions of CR, our AD-CR Score is a fully non-parametric, stand-alone, individual-level quantification of CR that is derived independently of other factors or proxy variables. Using data from two ongoing, longitudinal cohort studies of aging, the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP), we validate our AD-CR Score by showing strong associations with known factors related to CR such as baseline and longitudinal cognition, non AD-related pathology, education, personality, APOE, parkinsonism, depression, and life activities. Even though the proposed AD-CR Score cannot be directly calculated during an individual's lifetime because it uses postmortem pathology, we also develop a machine learning framework that achieves promising results in terms of predicting whether an individual will have an extremely high or low AD-CR Score using only measures available during the lifetime. Given this, our AD-CR Score can be used for further investigations into mechanisms of CR, and potentially for subject stratification prior to clinical trials of personalized therapies.
doi_str_mv 10.1371/journal.pone.0241707
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2457964030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A640707209</galeid><doaj_id>oai_doaj_org_article_87e04051c3b04fd295bb342fd5bb716c</doaj_id><sourcerecordid>A640707209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-a7c4e7de8d02a6934acf5d5bc3cddfff4a30b462b15e7bdbde6b47181e7727a03</originalsourceid><addsrcrecordid>eNqNk11v0zAUhiMEYmPwDxBEQuLjosVfiRMukKryVWnSxDa4tRznJPVw7WInE-PX465ZaVAvkC9sHT_nPfax3yR5itEUU47fXrneW2mma2dhigjDHPF7yTEuKZnkBNH7e-uj5FEIVwhltMjzh8kRpTgjiBTHyY-vvbSdbm60bVPlWqs7fQ2ph6CNBqsg1Tadmd9L0Cvwr0L6QQeQAd6ll0s4tJHOdyLnf0UulPPwOHnQSBPgyTCfJN8-fbycf5mcnn1ezGenE5WXpJtIrhjwGooaEZmXlEnVZHVWKarqumkaJimqWE4qnAGv6qqGvGIcFxg4J1wiepI83-qujQti6FMQhGW8zBmiG2KxJWonr8Ta65X0N8JJLW4DzrdC-k4rA6LggBjKsKIVYk1NyqyqKCNNPFDFca6i1vuhWl-toFZgOy_NSHS8Y_VStO5a8JzRMqdR4PUg4N3PHkInVjooMEZacP3tuQtEM8qyiL74Bz18u4FqZbyAto2LddVGVMwiEf8JQWWkpgeoOGpYaRU_VaNjfJTwZpQQmQ5-da3sQxCLi_P_Z8--j9mXe-wSpOmWwZm-086GMci2oPIuBA_NrskYiY0n7rohNp4Qgydi2rP9B9ol3ZmA_gHoQgfJ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2457964030</pqid></control><display><type>article</type><title>Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Yao, Tianyi ; Sweeney, Elizabeth ; Nagorski, John ; Shulman, Joshua M ; Allen, Genevera I</creator><contributor>Ginsberg, Stephen D.</contributor><creatorcontrib>Yao, Tianyi ; Sweeney, Elizabeth ; Nagorski, John ; Shulman, Joshua M ; Allen, Genevera I ; Ginsberg, Stephen D.</creatorcontrib><description>Even though there is a clear link between Alzheimer's Disease (AD) related neuropathology and cognitive decline, numerous studies have observed that healthy cognition can exist in the presence of extensive AD pathology, a phenomenon sometimes called Cognitive Resilience (CR). To better understand and study CR, we develop the Alzheimer's Disease Cognitive Resilience Score (AD-CR Score), which we define as the difference between the observed and expected cognition given the observed level of AD pathology. Unlike other definitions of CR, our AD-CR Score is a fully non-parametric, stand-alone, individual-level quantification of CR that is derived independently of other factors or proxy variables. Using data from two ongoing, longitudinal cohort studies of aging, the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP), we validate our AD-CR Score by showing strong associations with known factors related to CR such as baseline and longitudinal cognition, non AD-related pathology, education, personality, APOE, parkinsonism, depression, and life activities. Even though the proposed AD-CR Score cannot be directly calculated during an individual's lifetime because it uses postmortem pathology, we also develop a machine learning framework that achieves promising results in terms of predicting whether an individual will have an extremely high or low AD-CR Score using only measures available during the lifetime. Given this, our AD-CR Score can be used for further investigations into mechanisms of CR, and potentially for subject stratification prior to clinical trials of personalized therapies.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0241707</identifier><identifier>PMID: 33152028</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Aging ; Alzheimer Disease - diagnosis ; Alzheimer Disease - physiopathology ; Alzheimer's disease ; Apolipoprotein E ; Autopsy ; Basal ganglia ; Biology and Life Sciences ; Brain research ; Central nervous system diseases ; Clinical trials ; Cognition ; Cognition &amp; reasoning ; Cognitive ability ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - physiopathology ; Cognitive tests ; Cohort Studies ; Computer and Information Sciences ; Dementia ; Education ; Evaluation ; Exercise ; Health aspects ; Humans ; Learning algorithms ; Longitudinal Studies ; Machine learning ; Magnetic resonance imaging ; Mathematical analysis ; Medicine ; Medicine and Health Sciences ; Memory ; Methods ; Movement disorders ; Neurodegenerative diseases ; Neuropathology ; Pathology ; Public health ; Resilience ; Sweeney, John ; Variables</subject><ispartof>PloS one, 2020-11, Vol.15 (11), p.e0241707-e0241707</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Yao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Yao et al 2020 Yao et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-a7c4e7de8d02a6934acf5d5bc3cddfff4a30b462b15e7bdbde6b47181e7727a03</citedby><cites>FETCH-LOGICAL-c692t-a7c4e7de8d02a6934acf5d5bc3cddfff4a30b462b15e7bdbde6b47181e7727a03</cites><orcidid>0000-0001-8380-2866</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643963/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643963/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33152028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Ginsberg, Stephen D.</contributor><creatorcontrib>Yao, Tianyi</creatorcontrib><creatorcontrib>Sweeney, Elizabeth</creatorcontrib><creatorcontrib>Nagorski, John</creatorcontrib><creatorcontrib>Shulman, Joshua M</creatorcontrib><creatorcontrib>Allen, Genevera I</creatorcontrib><title>Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Even though there is a clear link between Alzheimer's Disease (AD) related neuropathology and cognitive decline, numerous studies have observed that healthy cognition can exist in the presence of extensive AD pathology, a phenomenon sometimes called Cognitive Resilience (CR). To better understand and study CR, we develop the Alzheimer's Disease Cognitive Resilience Score (AD-CR Score), which we define as the difference between the observed and expected cognition given the observed level of AD pathology. Unlike other definitions of CR, our AD-CR Score is a fully non-parametric, stand-alone, individual-level quantification of CR that is derived independently of other factors or proxy variables. Using data from two ongoing, longitudinal cohort studies of aging, the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP), we validate our AD-CR Score by showing strong associations with known factors related to CR such as baseline and longitudinal cognition, non AD-related pathology, education, personality, APOE, parkinsonism, depression, and life activities. Even though the proposed AD-CR Score cannot be directly calculated during an individual's lifetime because it uses postmortem pathology, we also develop a machine learning framework that achieves promising results in terms of predicting whether an individual will have an extremely high or low AD-CR Score using only measures available during the lifetime. Given this, our AD-CR Score can be used for further investigations into mechanisms of CR, and potentially for subject stratification prior to clinical trials of personalized therapies.</description><subject>Aging</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer's disease</subject><subject>Apolipoprotein E</subject><subject>Autopsy</subject><subject>Basal ganglia</subject><subject>Biology and Life Sciences</subject><subject>Brain research</subject><subject>Central nervous system diseases</subject><subject>Clinical trials</subject><subject>Cognition</subject><subject>Cognition &amp; reasoning</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - physiopathology</subject><subject>Cognitive tests</subject><subject>Cohort Studies</subject><subject>Computer and Information Sciences</subject><subject>Dementia</subject><subject>Education</subject><subject>Evaluation</subject><subject>Exercise</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Learning algorithms</subject><subject>Longitudinal Studies</subject><subject>Machine learning</subject><subject>Magnetic resonance imaging</subject><subject>Mathematical analysis</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Memory</subject><subject>Methods</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Neuropathology</subject><subject>Pathology</subject><subject>Public health</subject><subject>Resilience</subject><subject>Sweeney, John</subject><subject>Variables</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk11v0zAUhiMEYmPwDxBEQuLjosVfiRMukKryVWnSxDa4tRznJPVw7WInE-PX465ZaVAvkC9sHT_nPfax3yR5itEUU47fXrneW2mma2dhigjDHPF7yTEuKZnkBNH7e-uj5FEIVwhltMjzh8kRpTgjiBTHyY-vvbSdbm60bVPlWqs7fQ2ph6CNBqsg1Tadmd9L0Cvwr0L6QQeQAd6ll0s4tJHOdyLnf0UulPPwOHnQSBPgyTCfJN8-fbycf5mcnn1ezGenE5WXpJtIrhjwGooaEZmXlEnVZHVWKarqumkaJimqWE4qnAGv6qqGvGIcFxg4J1wiepI83-qujQti6FMQhGW8zBmiG2KxJWonr8Ta65X0N8JJLW4DzrdC-k4rA6LggBjKsKIVYk1NyqyqKCNNPFDFca6i1vuhWl-toFZgOy_NSHS8Y_VStO5a8JzRMqdR4PUg4N3PHkInVjooMEZacP3tuQtEM8qyiL74Bz18u4FqZbyAto2LddVGVMwiEf8JQWWkpgeoOGpYaRU_VaNjfJTwZpQQmQ5-da3sQxCLi_P_Z8--j9mXe-wSpOmWwZm-086GMci2oPIuBA_NrskYiY0n7rohNp4Qgydi2rP9B9ol3ZmA_gHoQgfJ</recordid><startdate>20201105</startdate><enddate>20201105</enddate><creator>Yao, Tianyi</creator><creator>Sweeney, Elizabeth</creator><creator>Nagorski, John</creator><creator>Shulman, Joshua M</creator><creator>Allen, Genevera I</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8380-2866</orcidid></search><sort><creationdate>20201105</creationdate><title>Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score</title><author>Yao, Tianyi ; Sweeney, Elizabeth ; Nagorski, John ; Shulman, Joshua M ; Allen, Genevera I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-a7c4e7de8d02a6934acf5d5bc3cddfff4a30b462b15e7bdbde6b47181e7727a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aging</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer's disease</topic><topic>Apolipoprotein E</topic><topic>Autopsy</topic><topic>Basal ganglia</topic><topic>Biology and Life Sciences</topic><topic>Brain research</topic><topic>Central nervous system diseases</topic><topic>Clinical trials</topic><topic>Cognition</topic><topic>Cognition &amp; reasoning</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - physiopathology</topic><topic>Cognitive tests</topic><topic>Cohort Studies</topic><topic>Computer and Information Sciences</topic><topic>Dementia</topic><topic>Education</topic><topic>Evaluation</topic><topic>Exercise</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Learning algorithms</topic><topic>Longitudinal Studies</topic><topic>Machine learning</topic><topic>Magnetic resonance imaging</topic><topic>Mathematical analysis</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Memory</topic><topic>Methods</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Neuropathology</topic><topic>Pathology</topic><topic>Public health</topic><topic>Resilience</topic><topic>Sweeney, John</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yao, Tianyi</creatorcontrib><creatorcontrib>Sweeney, Elizabeth</creatorcontrib><creatorcontrib>Nagorski, John</creatorcontrib><creatorcontrib>Shulman, Joshua M</creatorcontrib><creatorcontrib>Allen, Genevera I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yao, Tianyi</au><au>Sweeney, Elizabeth</au><au>Nagorski, John</au><au>Shulman, Joshua M</au><au>Allen, Genevera I</au><au>Ginsberg, Stephen D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020-11-05</date><risdate>2020</risdate><volume>15</volume><issue>11</issue><spage>e0241707</spage><epage>e0241707</epage><pages>e0241707-e0241707</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Even though there is a clear link between Alzheimer's Disease (AD) related neuropathology and cognitive decline, numerous studies have observed that healthy cognition can exist in the presence of extensive AD pathology, a phenomenon sometimes called Cognitive Resilience (CR). To better understand and study CR, we develop the Alzheimer's Disease Cognitive Resilience Score (AD-CR Score), which we define as the difference between the observed and expected cognition given the observed level of AD pathology. Unlike other definitions of CR, our AD-CR Score is a fully non-parametric, stand-alone, individual-level quantification of CR that is derived independently of other factors or proxy variables. Using data from two ongoing, longitudinal cohort studies of aging, the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP), we validate our AD-CR Score by showing strong associations with known factors related to CR such as baseline and longitudinal cognition, non AD-related pathology, education, personality, APOE, parkinsonism, depression, and life activities. Even though the proposed AD-CR Score cannot be directly calculated during an individual's lifetime because it uses postmortem pathology, we also develop a machine learning framework that achieves promising results in terms of predicting whether an individual will have an extremely high or low AD-CR Score using only measures available during the lifetime. Given this, our AD-CR Score can be used for further investigations into mechanisms of CR, and potentially for subject stratification prior to clinical trials of personalized therapies.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33152028</pmid><doi>10.1371/journal.pone.0241707</doi><tpages>e0241707</tpages><orcidid>https://orcid.org/0000-0001-8380-2866</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2020-11, Vol.15 (11), p.e0241707-e0241707
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2457964030
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Aging
Alzheimer Disease - diagnosis
Alzheimer Disease - physiopathology
Alzheimer's disease
Apolipoprotein E
Autopsy
Basal ganglia
Biology and Life Sciences
Brain research
Central nervous system diseases
Clinical trials
Cognition
Cognition & reasoning
Cognitive ability
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - physiopathology
Cognitive tests
Cohort Studies
Computer and Information Sciences
Dementia
Education
Evaluation
Exercise
Health aspects
Humans
Learning algorithms
Longitudinal Studies
Machine learning
Magnetic resonance imaging
Mathematical analysis
Medicine
Medicine and Health Sciences
Memory
Methods
Movement disorders
Neurodegenerative diseases
Neuropathology
Pathology
Public health
Resilience
Sweeney, John
Variables
title Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T03%3A42%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantifying%20cognitive%20resilience%20in%20Alzheimer's%20Disease:%20The%20Alzheimer's%20Disease%20Cognitive%20Resilience%20Score&rft.jtitle=PloS%20one&rft.au=Yao,%20Tianyi&rft.date=2020-11-05&rft.volume=15&rft.issue=11&rft.spage=e0241707&rft.epage=e0241707&rft.pages=e0241707-e0241707&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0241707&rft_dat=%3Cgale_plos_%3EA640707209%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2457964030&rft_id=info:pmid/33152028&rft_galeid=A640707209&rft_doaj_id=oai_doaj_org_article_87e04051c3b04fd295bb342fd5bb716c&rfr_iscdi=true